Phoenix Molecular Designs
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8755 Ash St Ste 1, Vancouver, British Co...Phone Number
(604) 674-1796Website
www.phoenixmd.caRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Phoenix Molecular Designs
Phoenix Molecular Designs is a Vancouver-based biotechnology company founded by Dr. Sandra Dunn, focusing on developing targeted small molecule drugs for Triple Negative Breast Cancer. The company specializes in RSK inhibitors and companion diagnostics, aiming to improve cancer treatment outcomes by tailoring therapies to the genetic makeup of tumors. Their lead candidate, PMD-026, is currently undergoing a Phase 2 clinical trial for breast cancer patients. With a commitment to precision medicine, they strive to enhance the quality of life for cancer patients through innovative therapeutic solutions.Explore more
Phoenix Molecular Designs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phoenix Molecular Designs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Phoenix Molecular Designs has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Phoenix Molecular Designs is spiking on competitors!
Click to see if Phoenix Molecular Designs had a recent Job posting/layoffs
Check if Phoenix Molecular Designs has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Phoenix Molecular Designs, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Phoenix Molecular Designs
Earning: See what the market has to say on Phoenix Molecular Designs recently announced quarterly report
Product Launch: Get notified when Phoenix Molecular Designs launches new products
Recommended Actions
Reach out to Masked Content who joined Phoenix Molecular Designs as Masked Content
Find 3 more new buyers
Compare Similar Companies to Phoenix Molecular Designs
Compare insights from companies similar to Phoenix Molecular Designs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phoenix Molecular Designs is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Phoenix Molecular Designs is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Phoenix Molecular Designs.
Phoenix Molecular Designs financials insights
Gather financial insights about Phoenix Molecular Designs, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$12M
Phoenix Molecular Designs Tech Stack
A closer look at the technologies used by Phoenix Molecular Designs
Phoenix Molecular Designs News & Media
Leader in Breast Cancer First-in-Class Drug Development, Martin S. Olivo, MD, MSc, joins Phoenix Molecular Designs Advisory Board
SAN DIEGO and VANCOUVER, BC, Oct. 27, 2022 /PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a clinical-stage biopharmaceutical company dedicated to developing precise cancer therapeutics, today announced the appointment of Martin S. Olivo, MD, MSc to its advisory board. Dr. Olivo is...Phoenix Molecular Designs Successfully Completes Patient Enrollment in Phase 1/1b Clinical Trial of PMD-026
SAN DIEGO and VANCOUVER, BC, Feb. 9, 2022 /PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a clinical stage biopharmaceutical company dedicated to developing precise cancer therapeutics, today announced the completion of patient enrollment and dosing of PMD-026 in their Phase 1b...Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael Varney, Ph.D., to its Advisory Board
SAN DIEGO, California and VANCOUVER, BC, March 29, 2021 /PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a company on a mission to help thousands of patients and their families battling triple negative breast cancer (TNBC) by developing first-in-class RSK kinase inhibitors, today...World-Renowned Cancer Researcher, Dr. Alan Ashworth, Joins Phoenix Molecular Designs Advisory Board
SAN DIEGO and VANCOUVER, BC, Feb. 4, 2021 /PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), an industry leader in the development of precise cancer therapeutics focusing on first-in-class RSK kinase inhibitors, today announced the appointment of Dr. Alan Ashworth PhD, FRS to their...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Phoenix Molecular Designs
Sign Up For FreeTo access detailed company insights
Phoenix Molecular Designs is a Vancouver-based biotechnology company founded by Dr. Sandra Dunn, focusing on developing targeted small molecule drugs for Triple Negative Breast Cancer. The company specializes in RSK inhibitors and companion diagnostics, aiming to improve cancer treatment outcomes by tailoring therapies to the genetic makeup of tumo... Read More
